SCHEMBL6313587

SCHEMBL6313587

Fc1ccc(C#Cc2nccs2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 4/20 0.68
ACACB O00763 1/20 0.48
PDE10A Q9Y233 2/20 0.46
HAO1 Q9UJM8 2/20 0.44
FBP1 P09467 1/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.41
NFKB1 P19838 1/20 0.41
AGTR1 P30556 1/20 0.41
HTT P42858 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SYK P43405 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30278513 0.81 GRM5 (0.68) GRM5ACACBPDE10AHAO1FBP1
SCHEMBL4747174 0.81 GRM5 (0.68) GRM5ACACBPDE10AHAO1FBP1
SCHEMBL6311975 0.81 GRM5 (1.00) GRM5ACACBPDE10AHAO1
SCHEMBL15870993 0.79 GRM5 (0.68) GRM5ACACBPDE10AHAO1FBP1
SCHEMBL702812 0.77 GRM5 (0.62) GRM5ACACBPDE10AHAO1FBP1
SCHEMBL10236313 0.77 GRM5 (0.62) GRM5ACACBPDE10AHAO1
SCHEMBL7717366 0.72 GRM5 (0.50) GRM5HAO1TP53
SCHEMBL718949 0.72 GRM5 (0.50) GRM5HAO1TP53
SCHEMBL10300106 0.72 GRM5 (0.50) GRM5HAO1TP53
SCHEMBL30278516 0.72 GRM5 (0.47) GRM5ACACBPDE10AHAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6956049-B1 Methods of modulating processes mediated by excitatory amino acid receptors MERCK & CO., INC. (US) 2005-10-18 US disclosed
EP-1214303-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Merck & Co., Inc. (US) 2002-06-19 EP disclosed
WO-2001016121-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2001-03-08 WO disclosed